Michael Matson
Stock Analyst at Needham
(4.27)
# 1,427
Out of 4,634 analysts
1591
Total ratings
50.9%
Success rate
6.4%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnostics | Rated: Buy | $9 | $4.77 | +88.68% | 36 | Aug 11, 2026 | |
| AORT Artivion | Reiterated: Buy | $44 | $26.31 | +67.24% | 61 | Aug 7, 2026 | |
| ICUI ICU Medical | Rated: Buy | $165 → $187 | $182.42 | +2.51% | 14 | Aug 7, 2026 | |
| RMD ResMed | Maintained: Hold | n/a | $220.05 | - | 96 | Aug 7, 2026 | |
| INGN Inogen | Rated: Buy | $12 | $6.02 | +99.34% | 87 | Aug 7, 2026 | |
| ENOV Enovis | Reiterated: Buy | $52 | $24.24 | +114.52% | 18 | Aug 6, 2026 | |
| HAE Haemonetics | Maintained: Hold | n/a | $86.61 | - | 47 | Aug 6, 2026 | |
| STE STERIS | Maintained: Hold | n/a | $238.91 | - | 34 | Aug 6, 2026 | |
| TFX Teleflex | Maintained: Buy | $159 | $133.00 | +19.55% | 71 | Aug 6, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $86 → $95 | $75.06 | +26.57% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $14.50 | - | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $97.78 | - | 89 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $93 | $76.48 | +21.60% | 87 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $23.28 | +50.34% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.19 | - | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $142 → $106 | $88.41 | +19.90% | 29 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $101 | $89.75 | +12.53% | 69 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $418 | $345.81 | +20.88% | 74 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $69 | $46.27 | +49.12% | 36 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $49.46 | - | 83 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 | $50.46 | +12.96% | 128 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $19 | $16.63 | +14.25% | 39 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $41.64 | +8.07% | 103 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $89.41 | +12.96% | 97 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.9611 | +212.14% | 32 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $325.98 | - | 24 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.035 | n/a | 2 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 → $82 | $86.15 | n/a | 22 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $18.84 | n/a | 1 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.27 | n/a | 50 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.70 | n/a | 10 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $9.75 | n/a | 1 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $636 | $393.38 | n/a | 1 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $15 → $14 | $9.65 | n/a | 4 | Apr 9, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $10.26 | n/a | 1 | Apr 17, 2009 |
Insight Molecular Diagnostics
Aug 11, 2026
Rated: Buy
Price Target: $9
Current: $4.77
Upside: +88.68%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $44
Current: $26.31
Upside: +67.24%
ICU Medical
Aug 7, 2026
Rated: Buy
Price Target: $165 → $187
Current: $182.42
Upside: +2.51%
ResMed
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $220.05
Upside: -
Inogen
Aug 7, 2026
Rated: Buy
Price Target: $12
Current: $6.02
Upside: +99.34%
Enovis
Aug 6, 2026
Reiterated: Buy
Price Target: $52
Current: $24.24
Upside: +114.52%
Haemonetics
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $86.61
Upside: -
STERIS
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $238.91
Upside: -
Teleflex
Aug 6, 2026
Maintained: Buy
Price Target: $159
Current: $133.00
Upside: +19.55%
Establishment Labs Holdings
Aug 6, 2026
Reiterated: Buy
Price Target: $86 → $95
Current: $75.06
Upside: +26.57%
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $14.50
Upside: -
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $97.78
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: $81 → $93
Current: $76.48
Upside: +21.60%
Aug 5, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $23.28
Upside: +50.34%
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $15.19
Upside: -
Aug 3, 2026
Rated: Buy
Price Target: $142 → $106
Current: $88.41
Upside: +19.90%
Jul 31, 2026
Reiterated: Buy
Price Target: $90 → $101
Current: $89.75
Upside: +12.53%
Jul 31, 2026
Reiterated: Buy
Price Target: $418
Current: $345.81
Upside: +20.88%
Jul 31, 2026
Reiterated: Buy
Price Target: $57 → $69
Current: $46.27
Upside: +49.12%
Jul 30, 2026
Maintained: Hold
Price Target: n/a
Current: $49.46
Upside: -
Jul 29, 2026
Maintained: Buy
Price Target: $57
Current: $50.46
Upside: +12.96%
Jul 29, 2026
Rated: Buy
Price Target: $15 → $19
Current: $16.63
Upside: +14.25%
Jul 24, 2026
Reiterated: Buy
Price Target: $45
Current: $41.64
Upside: +8.07%
Jun 17, 2026
Reiterated: Buy
Price Target: $101
Current: $89.41
Upside: +12.96%
May 14, 2026
Reiterated: Buy
Price Target: $3
Current: $0.9611
Upside: +212.14%
Feb 25, 2026
Maintained: Hold
Price Target: n/a
Current: $325.98
Upside: -
Apr 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.035
Upside: n/a
May 5, 2021
Maintained: Buy
Price Target: $65 → $82
Current: $86.15
Upside: n/a
Mar 18, 2020
Maintained: Buy
Price Target: $27
Current: $18.84
Upside: n/a
Dec 6, 2018
Rated: Hold
Price Target: n/a
Current: $4.27
Upside: n/a
Nov 11, 2016
Maintained: Buy
Price Target: n/a
Current: $1.70
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $1
Current: $9.75
Upside: n/a
Apr 19, 2013
Maintained: Buy
Price Target: $636
Current: $393.38
Upside: n/a
Apr 9, 2013
Upgraded: Buy
Price Target: $15 → $14
Current: $9.65
Upside: n/a
Apr 17, 2009
Downgraded: Sell
Price Target: n/a
Current: $10.26
Upside: n/a